EcoR1 Capital LLC 13D and 13G filings for Edgewise Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 6:22 pm Sale |
2024-09-30 | 13G | Edgewise Therapeutics, Inc. EWTX |
EcoR1 Capital LLC | 1,250,385 1.300% |
-2,242,809 (-64.21%) |
Filing |
| 2022-09-26 4:06 pm Purchase |
2022-09-14 | 13G | Edgewise Therapeutics, Inc. EWTX |
EcoR1 Capital LLC | 3,493,194 5.500% |
3,493,194 (New Position) |
Filing |